遗传性乳腺和卵巢癌:从基因到分子向疗法
Giovanni Ponti1, Carmine De Angelis2, Rosamaria Ponti2
1Division of Clinical Pathology, Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Critical reviews in clinical laboratory sciences
|July 17, 2023
概括
与BRCA1/2突变相关的遗传性乳腺和卵巢癌 (HBOC) 提供了个性化治疗. 识别BRCA1/2突变指导诊断,预后和治疗,包括BRCA+癌症的PARP抑制剂.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 个性化医疗是个性化的医疗.
背景情况:
- 遗传性家族瘤占所有癌症的10-15%,为生殖系遗传缺陷治疗提供了点.
- 由BRCA1/2基因突变引起的遗传性乳腺和卵巢癌 (HBOC) 综合征是个性化治疗策略的典范.
- 在家庭中,HBOC是由早期发病 (<36岁),双边和多种癌症类型 (乳腺,卵巢,前列腺,胰腺,胃) 定义的,以自体主导模式遗传.
研究的目的:
- 审查遗传性癌症中BRCA1/2突变状态的诊断,预后和预测价值.
- 突出识别BRCA1/2突变的治疗含义,特别是在乳腺癌管理中.
- 强调基因检测和咨询在治疗HBOC综合征中的作用.
主要方法:
- 文献综述总结了遗传性癌症中BRCA1/2状态的证据.
- 对HBOC的诊断标准和遗传检测协议的分析.
- 对BRCA突变癌症的治疗策略的评估,包括PARP抑制剂.
主要成果:
- BRCA1/2突变状态是一个有价值的诊断和预后工具.
- 鉴定BRCA1/2突变对乳腺癌患者具有重大治疗意义.
- 聚 (ADP-ribose) 聚合酶 (PARP) 抑制剂通过阻止DNA修复,在治疗BRCA突变癌症方面表现出显著的疗效.
结论:
- 对于遗传性癌症的个性化管理,BRCA1/2检测至关重要.
- 像PARP抑制剂这样的向疗法在治疗BRCA突变恶性瘤方面取得了重大进展.
- 了解生殖系遗传缺陷是推进个性化瘤治疗的关键.
关键词:
这就是BRCA1的原因.这就是BRCA2的原因.遗传性乳腺癌是一种遗传性乳腺癌.在 PARP 抑制剂的使用中.遗传性卵巢癌 遗传性的卵巢癌遗传性瘤是一种遗传性瘤.尼拉帕里布里布里布.这就是Olapramib.塔拉索帕里比 (Talazoparib) 是一种可怕的药物.更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.3K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
01:33Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K